From BZ’s Small Cap Healthcare Conference: Vivos Therapeutics CEO, R. Kirk Huntsman Begins Presenting
Click To Tune In Here...https://www.youtube.com/watch?v=KS30Mcu5ei8
16 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) rose 29.7% to $5.42 in pre-market trading after the company reported the purchase of exclusive rights to PNP Therapeutics' development and commercialization of Gedeptin.
Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment
Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients
Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide
Midway through trading Tuesday, the Dow traded up 0.09% to 35,368.20 while the NASDAQ rose 0.40% to 15,001.95. The S&P also rose, gaining 0.14% to 4,486.01.
38 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc, will acquire Triple-S Management for an equity value of approximately $900 million.
Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates
Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23.
